Clinical Trial Update: DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis

View source ↗

Summary

A completed observational trial (DISCOVERY) evaluated the prevalence of transthyretin (TTR) mutations in subjects suspected of having cardiac amyloidosis, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis
• Familial Transthyretin-mediated Cardiomyopathy

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Familial Amyloidotic Cardiomyopathy (FAC) | Status: COMPLETED